Showing 12,281 - 12,300 results of 42,560 for search '(( 50 ((((we decrease) OR (mean decrease))) OR (a decrease)) ) OR ( a point decrease ))', query time: 1.14s Refine Results
  1. 12281

    DataSheet1_Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain.docx by Malene Brohus (840080)

    Published 2023
    “…The impact was most severe at low and intermediate Ca<sup>2+</sup> concentrations (up to 4 µM) resulting in more than a 50-fold reduction in Na<sub>V</sub>1.5 binding affinity, and a smaller 1.5 to 11-fold reduction at high Ca<sup>2+</sup> concentrations (25–400 µM). …”
  2. 12282
  3. 12283

    Reduction of IL-17 after co-administration of donor-derived MSCs and Treg cells. by Eun-Sol Lee (737390)

    Published 2015
    “…<p>Recipient mice were evaluated at different time points after BMT. (A) The percentage of CD4<sup>+</sup> IL-17<sup>+</sup> cells and CD4<sup>+</sup> IL-6<sup>+</sup> cells were identified by flow cytometry at 12 days after BMT (<i>n</i> = 6). …”
  4. 12284
  5. 12285
  6. 12286

    Image_2_Vitamin A deficiency in the MENA region: a 30-year analysis (1990–2019).JPEG by Saeid Safiri (3713035)

    Published 2024
    “…The age-standardized prevalence [50.3% (−55.9 to −44.7)] and YLD [−49.3% (−55.3 to −43.1)] rates of VAD have significantly decreased since 1990. …”
  7. 12287

    Image_1_Vitamin A deficiency in the MENA region: a 30-year analysis (1990–2019).JPEG by Saeid Safiri (3713035)

    Published 2024
    “…The age-standardized prevalence [50.3% (−55.9 to −44.7)] and YLD [−49.3% (−55.3 to −43.1)] rates of VAD have significantly decreased since 1990. …”
  8. 12288
  9. 12289

    Dynamics of Ca<sup>2+</sup> using <i>PLC</i> as a parameter for doses of <i>a</i> ≤ 1 <i>μ</i>g/ml of A<i>β</i>. by Joseph Minicucci (10047331)

    Published 2021
    “…<b>C</b> shows the two parameter bifurcation diagram when both <i>PLC</i> and <i>a</i> are varied. Note that only the small doses of <i>a</i> are considered and the region of oscillations shifts to the right as <i>a</i> decreases and <i>PLC</i> increases. …”
  10. 12290
  11. 12291
  12. 12292
  13. 12293
  14. 12294
  15. 12295
  16. 12296
  17. 12297

    The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors by T. Ghiasi (10910038)

    Published 2021
    “…<p>Robust and reliable QSAR models were developed to predict half-maximal inhibitory concentration (IC<sub>50</sub>) values of hepatitis C virus NS3/4A protease inhibitors from the Monte Carlo technique. 524 HCV NS3/4A protease inhibitors were extracted from the scientific literature to create a reasonably large set. …”
  18. 12298

    Uptake of the fluorescent glucose analog 2-NBDG is mediated by SGLT2 in KPT2 cells. by Meiyan Jiang (438439)

    Published 2014
    “…Increasing doses of (C–F) D-glucose (molar ratios of 1∶0, 1∶1, 1∶50 or 1∶1000 [2-NBDG/D-glucose]), or (G–J) phlorizin (molar ratios of 1∶0, 1∶1, 1∶10 or 1∶50 [2-NBDG/phlorizin]) dose-dependently decreased 2-NBDG fluorescence in KPT2. …”
  19. 12299

    The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice by Michael Bobardt (238998)

    Published 2020
    “…These findings demonstrate for the first time that an inhibitor of apoptosis protein antagonist enhances in a statistically manner the effects of an immune check point inhibitor on antiviral immunity and on HIV load reduction in tissues of humanized mice, suggesting that the combination of two distinct classes of immunomodulatory agents constitutes a promising anti-HIV immunotherapeutic approach.…”
  20. 12300